{
  "id": 184214,
  "title": "Attovia adds to biotech IPO momentum with $289M offering",
  "url": "https://urgent.news/2026/08/05/attovia-adds-to-biotech-ipo-momentum-with-289m-offering",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-05T16:05:25.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/attovia-biotech-ipo-price-eczema-pruritis-drugs/827061/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The startup is the 12th drug company to bank at least $250 million in an IPO this year, nearly matching totals last seen during the sector’s pandemic peak, according to BioPharma Dive data.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Attovia extends biotech IPO streak with $289M listing for three I&I drugs",
        "url": "https://urgent.news/2026/08/05/attovia-extends-biotech-ipo-streak-with-289m-listing-for-three-i-i",
        "published": "2026-08-05T11:00:13.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}